HSA grants PSAR for Rapigen's BIOCREDIT COVID-19 Ag Home Test Nasal
of 23 February 2022, Singapore Health Sciences Authority (HSA) has authorized BIOCREDIT
COVID-19 OTC self-test kits for use in Singapore.
Rapigen's BIOCREDIT COVID-19 Ag Home Test Nasal kits will be available in stores from March amid Singapore logging a record high of 18,162 new Covid-19 cases on March 3, a total of 785,825 accumulated cases thus far.
For self-tests that have been authorized by HSA under PSAR, please visit :
(*PSAR : Pandemic Special Access Route)